Corcept Therapeutics (CORT) is down -15.0%, or -$13.26 to $75.11.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept Therapeutics Board Member Resigns, Continues as Consultant
- Corcept Therapeutics management to meet with Truist
- 3 ‘Outperform’ Healthcare Stocks, According to AI Analyst, 9/10/25
- Corcept Therapeutics price target raised to $140 from $137 at Canaccord
- Corcept Therapeutics’ New Drug Application Accepted by FDA